Discordance in investigator-reported and adjudicated sudden death in TIOSPIR

Robert A. Wise, Peter R. Kowey, George Austen, Achim Mueller, Norbert Metzdorf, Andy Fowler, Lorcan P. McGarvey

Research output: Contribution to journalArticle

Abstract

Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17135) compared the safety and efficacy of tiotropium Respimat 5/2.5 μg with HandiHaler 18 μg in COPD patients. All-cause mortality was a primary end-point. A mortality adjudication committee (MAC) assessed all deaths. We aimed to investigate causes of discordance in investigator-reported and MAC-adjudicated causes of death and their impact on results, especially cardiac and sudden death. The MAC provided independent, blinded assessment of investigator-reported deaths (n=1302) and assigned underlying cause of death. Discordance between causes of death was assessed descriptively (shift tables). There was agreement between investigator-reported and MAC-adjudicated deaths in 69.4% of cases at the system organ class level. Differences were mainly observed for cardiac deaths (16.4% investigator, 5.1% MAC) and deaths assigned to general disorders including sudden death (17.4% investigator, 24.6% MAC). Reasons for discrepancies included investigator attribution to the immediate (e.g. myocardial infarction (MI)) over the underlying cause of death (e.g. COPD) and insufficient information for a definitive cause. Cause-specific mortality varies in COPD, depending on the method of assignment. Sudden death, witnessed and unwitnessed, is common in COPD and often attributed to MI without supporting evidence.

Original languageEnglish (US)
Article number00073-2016
JournalERS Monograph
Volume3
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Sudden Death
Research Personnel
Mortality
Chronic Obstructive Pulmonary Disease
Cause of Death
Myocardial Infarction
Sudden Cardiac Death
Safety

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Wise, R. A., Kowey, P. R., Austen, G., Mueller, A., Metzdorf, N., Fowler, A., & McGarvey, L. P. (2017). Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. ERS Monograph, 3(1), [00073-2016]. https://doi.org/10.1183/23120541.00073-2016

Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. / Wise, Robert A.; Kowey, Peter R.; Austen, George; Mueller, Achim; Metzdorf, Norbert; Fowler, Andy; McGarvey, Lorcan P.

In: ERS Monograph, Vol. 3, No. 1, 00073-2016, 01.01.2017.

Research output: Contribution to journalArticle

Wise, RA, Kowey, PR, Austen, G, Mueller, A, Metzdorf, N, Fowler, A & McGarvey, LP 2017, 'Discordance in investigator-reported and adjudicated sudden death in TIOSPIR', ERS Monograph, vol. 3, no. 1, 00073-2016. https://doi.org/10.1183/23120541.00073-2016
Wise RA, Kowey PR, Austen G, Mueller A, Metzdorf N, Fowler A et al. Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. ERS Monograph. 2017 Jan 1;3(1). 00073-2016. https://doi.org/10.1183/23120541.00073-2016
Wise, Robert A. ; Kowey, Peter R. ; Austen, George ; Mueller, Achim ; Metzdorf, Norbert ; Fowler, Andy ; McGarvey, Lorcan P. / Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. In: ERS Monograph. 2017 ; Vol. 3, No. 1.
@article{3ab986310ab6456e9ba64a44e06cbcb0,
title = "Discordance in investigator-reported and adjudicated sudden death in TIOSPIR",
abstract = "Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17135) compared the safety and efficacy of tiotropium Respimat 5/2.5 μg with HandiHaler 18 μg in COPD patients. All-cause mortality was a primary end-point. A mortality adjudication committee (MAC) assessed all deaths. We aimed to investigate causes of discordance in investigator-reported and MAC-adjudicated causes of death and their impact on results, especially cardiac and sudden death. The MAC provided independent, blinded assessment of investigator-reported deaths (n=1302) and assigned underlying cause of death. Discordance between causes of death was assessed descriptively (shift tables). There was agreement between investigator-reported and MAC-adjudicated deaths in 69.4{\%} of cases at the system organ class level. Differences were mainly observed for cardiac deaths (16.4{\%} investigator, 5.1{\%} MAC) and deaths assigned to general disorders including sudden death (17.4{\%} investigator, 24.6{\%} MAC). Reasons for discrepancies included investigator attribution to the immediate (e.g. myocardial infarction (MI)) over the underlying cause of death (e.g. COPD) and insufficient information for a definitive cause. Cause-specific mortality varies in COPD, depending on the method of assignment. Sudden death, witnessed and unwitnessed, is common in COPD and often attributed to MI without supporting evidence.",
author = "Wise, {Robert A.} and Kowey, {Peter R.} and George Austen and Achim Mueller and Norbert Metzdorf and Andy Fowler and McGarvey, {Lorcan P.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1183/23120541.00073-2016",
language = "English (US)",
volume = "3",
journal = "ERS Monograph",
issn = "2312-508X",
publisher = "European Respiratory Society",
number = "1",

}

TY - JOUR

T1 - Discordance in investigator-reported and adjudicated sudden death in TIOSPIR

AU - Wise, Robert A.

AU - Kowey, Peter R.

AU - Austen, George

AU - Mueller, Achim

AU - Metzdorf, Norbert

AU - Fowler, Andy

AU - McGarvey, Lorcan P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17135) compared the safety and efficacy of tiotropium Respimat 5/2.5 μg with HandiHaler 18 μg in COPD patients. All-cause mortality was a primary end-point. A mortality adjudication committee (MAC) assessed all deaths. We aimed to investigate causes of discordance in investigator-reported and MAC-adjudicated causes of death and their impact on results, especially cardiac and sudden death. The MAC provided independent, blinded assessment of investigator-reported deaths (n=1302) and assigned underlying cause of death. Discordance between causes of death was assessed descriptively (shift tables). There was agreement between investigator-reported and MAC-adjudicated deaths in 69.4% of cases at the system organ class level. Differences were mainly observed for cardiac deaths (16.4% investigator, 5.1% MAC) and deaths assigned to general disorders including sudden death (17.4% investigator, 24.6% MAC). Reasons for discrepancies included investigator attribution to the immediate (e.g. myocardial infarction (MI)) over the underlying cause of death (e.g. COPD) and insufficient information for a definitive cause. Cause-specific mortality varies in COPD, depending on the method of assignment. Sudden death, witnessed and unwitnessed, is common in COPD and often attributed to MI without supporting evidence.

AB - Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17135) compared the safety and efficacy of tiotropium Respimat 5/2.5 μg with HandiHaler 18 μg in COPD patients. All-cause mortality was a primary end-point. A mortality adjudication committee (MAC) assessed all deaths. We aimed to investigate causes of discordance in investigator-reported and MAC-adjudicated causes of death and their impact on results, especially cardiac and sudden death. The MAC provided independent, blinded assessment of investigator-reported deaths (n=1302) and assigned underlying cause of death. Discordance between causes of death was assessed descriptively (shift tables). There was agreement between investigator-reported and MAC-adjudicated deaths in 69.4% of cases at the system organ class level. Differences were mainly observed for cardiac deaths (16.4% investigator, 5.1% MAC) and deaths assigned to general disorders including sudden death (17.4% investigator, 24.6% MAC). Reasons for discrepancies included investigator attribution to the immediate (e.g. myocardial infarction (MI)) over the underlying cause of death (e.g. COPD) and insufficient information for a definitive cause. Cause-specific mortality varies in COPD, depending on the method of assignment. Sudden death, witnessed and unwitnessed, is common in COPD and often attributed to MI without supporting evidence.

UR - http://www.scopus.com/inward/record.url?scp=85032071608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032071608&partnerID=8YFLogxK

U2 - 10.1183/23120541.00073-2016

DO - 10.1183/23120541.00073-2016

M3 - Article

VL - 3

JO - ERS Monograph

JF - ERS Monograph

SN - 2312-508X

IS - 1

M1 - 00073-2016

ER -